EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 4 (Avril 2003) Med Sci (Paris), 19 4 (2003) 405-407 References
Free Access
Issue
Med Sci (Paris)
Volume 19, Number 4, Avril 2003
Page(s) 405 - 407
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/2003194405
Published online 15 April 2003
  1. Dalchau R, Kirkley J, Fabre JW. Monoclonal antibody to a human braingranulocyte- T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol 1980; 10: 745–9. [Google Scholar]
  2. Naor D, Sionov RV, Ish- Shalom D. CD44: Structure, function and association with the malignant process. In: Vande Woude GF, Klein G, eds. Advances in cancer research. San-Diego: Academic Press, 1997 : 243–318. [Google Scholar]
  3. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423–8. [Google Scholar]
  4. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994; 6: 726–33. [Google Scholar]
  5. Günthert U, Hofmann M, Rudy S, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65 : 13–24. [Google Scholar]
  6. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443–55. [Google Scholar]
  7. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 1993 : 361: 79–82. [Google Scholar]
  8. Bennett KL, Jackson DG, Simon JC, et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparinbinding growth factor. J Cell Biol 1995; 128: 687–98 [Google Scholar]
  9. Sherman L, Wainwright D, Ponta H, Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 1998; 12: 1058–71. [Google Scholar]
  10. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002; 16: 3074–86. [Google Scholar]
  11. Birchmeier C, Gherardi E Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404–10. [Google Scholar]
  12. Nestl A, Von Stein OD, Zatloukal K, et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001; 61: 1569–77. [Google Scholar]
  13. Legg JW, Isacke CM. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 1998; 8: 705–8. [Google Scholar]
  14. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993; 363: 515–21. [Google Scholar]
  15. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001; 15: 968–80. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.